A citation-based method for searching scientific literature

Christine Tunon-de-Lara, Marie Pierre Chauvet, Marie Christine Baranzelli, Marc Baron, Jean Piquenot, Guillaume Le-Bouédec, Fréderique Penault-Llorca, Jean-Rémi Garbay, Jérôme Blanchot, Joëlle Mollard, Véronique Maisongrosse, Simone Mathoulin-Pélissier, Gaëtan MacGrogan. Ann Surg Oncol 2015
Times Cited: 19







List of co-cited articles
176 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
479
47

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
47

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
40
36

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
205
36

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Jensen C C Tan, David R McCready, Alexandra M Easson, Wey L Leong. Ann Surg Oncol 2007
45
31

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
25
26

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
26

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
P Meijnen, H S A Oldenburg, C E Loo, O E Nieweg, J L Peterse, E J T Rutgers. Br J Surg 2007
64
26

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer.
Keiichiro Tada, Akiko Ogiya, Kiyomi Kimura, Hidetomo Morizono, Kotaro Iijima, Yumi Miyagi, Seiichiro Nishimura, Masujiro Makita, Rie Horii, Futoshi Akiyama,[...]. World J Surg Oncol 2010
19
21


Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
E Guillot, C Vaysse, J Goetgeluck, M C Falcou, B Couturaud, A Fitoussi, V Fourchotte, F Laki, C Malhaire, B Sigal-Zafrani,[...]. Breast 2014
12
33


Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
387
21


Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Mathias Worni, Igor Akushevich, Rachel Greenup, Deba Sarma, Marc D Ryser, Evan R Myers, E Shelley Hwang. J Natl Cancer Inst 2015
111
21

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
38
21

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
195
21

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
21


Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
Francisco J Dominguez, Mehra Golshan, Dalliah M Black, Kevin S Hughes, Michele A Gadd, Roger Christian, Beth-Ann Lesnikoski, Michelle Specht, James Michaelson, Barbara L Smith. Ann Surg Oncol 2008
36
21

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
158
21

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
232
21

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
21

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Laura A Vallow, Kathy S Albain, Patrick W Whitworth, Mary E Cianfrocca, Adam M Brufsky,[...]. Lancet 2016
92
21

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
138
21

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
202
21

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Hyung Seok Park, Seho Park, Junghoon Cho, Ji Min Park, Seung Il Kim, Byeong-Woo Park. J Surg Oncol 2013
45
21

Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Susan Prendeville, Ciara Ryan, Linda Feeley, Fionnuala O'Connell, Tara Jane Browne, Martin J O'Sullivan, Michael W Bennett. Breast 2015
24
21

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
27
21

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
97
21

The utility of sentinel lymph node biopsy in patients with ductal carcinoma in situ suspicious for microinvasion on core biopsy.
Jukes P Namm, Jeffrey Mueller, Masha Kocherginsky, Swati Kulkarni. Ann Surg Oncol 2015
11
27

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
211
15

Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast.
B Ansari, S A Ogston, C A Purdie, D J Adamson, D C Brown, A M Thompson. Br J Surg 2008
66
15

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Elizabeth A Mittendorf, Cletus A Arciero, Veronica Gutchell, Jeff Hooke, Craig D Shriver. Curr Surg 2005
67
15

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
35
15

Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
T J Meretoja, P S Heikkilä, K Salmenkivi, M H K Leidenius. Ann Surg Oncol 2012
21
15

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
M Leidenius, K Salmenkivi, K von Smitten, P Heikkilä. J Surg Oncol 2006
31
15

Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.
Melissa Pilewskie, Cristina Olcese, Anne Eaton, Sujata Patil, Elizabeth Morris, Monica Morrow, Kimberly J Van Zee. Ann Surg Oncol 2014
36
15

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
388
15

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
Julia S Wong, Yu-Hui Chen, Michele A Gadd, Rebecca Gelman, Susan C Lester, Stuart J Schnitt, Dennis C Sgroi, Barbara J Silver, Barbara L Smith, Susan L Troyan,[...]. Breast Cancer Res Treat 2014
70
15

Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.
Lars Holmberg, Hans Garmo, Bengt Granstrand, Anita Ringberg, Lars-Gunnar Arnesson, Kerstin Sandelin, Per Karlsson, Harald Anderson, Stefan Emdin. J Clin Oncol 2008
171
15

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
15

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
436
15

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Katrina H Moore, Karl J Sweeney, Meaghan E Wilson, Jessica I Goldberg, Claire L Buchanan, Lee K Tan, Laura Liberman, Roderick R Turner, Michael D Lagios, Hiram S Cody Iii,[...]. Ann Surg Oncol 2007
48
15

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Min Yi, Funda Meric-Bernstam, Henry M Kuerer, Elizabeth A Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F Hwang, Jaime R Crow, Sheng Luo, Kelly K Hunt. J Clin Oncol 2012
88
15

Palpable ductal carcinoma in situ: analysis of radiological and histological features of a large series with 5-year follow-up.
Sreekumar Sundara Rajan, Rashmi Verma, Abeer M Shaaban, Nisha Sharma, Barbara Dall, Mark Lansdown. Clin Breast Cancer 2013
10
30

Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
67
15

Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy.
Suzanne C E Diepstraten, Stephanie M W Y van de Ven, Ruud M Pijnappel, Petra H M Peeters, Maurice A A J van den Bosch, Helena M Verkooijen, Sjoerd G Elias. PLoS One 2013
12
25

Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.
Cindy B Matsen, Allison Hirsch, Anne Eaton, Michelle Stempel, Alexandra Heerdt, Kimberly J Van Zee, Hiram S Cody, Monica Morrow, George Plitas. Ann Surg Oncol 2014
27
15

Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Haruru Kotani, Akiyo Yoshimura, Yayoi Adachi, Junko Ishiguro, Tomoka Hisada, Mari Ichikawa, Naomi Gondou, Masaya Hattori, Naoto Kondou, Masataka Sawaki,[...]. Breast Cancer 2016
7
42


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.